Armando Anido, the CEO and Chairman of Zynerba, said that in its first human clinical trials of cannabinoids through transdermal delivery, they are …
Armando Anido, the CEO and Chairman of Zynerba, said that in its first human clinical trials of cannabinoids through transdermal delivery, they are …